Feb 14, 2020 (Xherald via COMTEX) -- Global Gastrointestinal Bleeding Treatment Market - Growth, Trends, And Forecast (2020 - 2025)
The report presents an in-depth assessment of the Global Gastrointestinal Bleeding Treatment including enabling technologies, key trends, market drivers, challenges, standardization, regulatory landscape, deployment models, operator case studies, opportunities, future roadmap, value chain, ecosystem player profiles and strategies. The report also presents forecasts for Global Gastrointestinal Bleeding Treatment investments from 2020 till 2025.
Click the link to get a Sample Copy of the Report:
The Global Gastrointestinal Bleeding Treatment market is highly competitive and consists of a number of major players. Companies, like Boston Scientific Corporation, CONMED Corporation, Cook Group, ERBE Elektromedizin GmbH, Olympus Corporation, Ovesco Endoscopy AG, STERIS PLC, US Medical Innovations among others.
Scope of the Report
As per the scope of the report, Gastrointestinal Bleeding refers to any form of hemorrhage or blood loss that occurs within the digestive organs like the esophagus, stomach, small intestine including the duodenum, rectum, etc. It includes all forms of bleeding of the gastrointestinal tract, from the mouth to the rectum.
(special offer:Get flat upto 20% discount on this report)
Inquire for Discount:
Upper GI Tract Segment is Expected to Register a Good Growth Over the Forecast Period
By GI tract division, the market has been segmented into Upper GI Tract, and Lower GI Tract. The upper GI tract accounted for major share in the gastrointestinal bleeding treatment market and this trend is likely to continue during the forecast period. A peptic ulcer is one of the most common causes of upper GI tract bleeding and is known to have increased prevalence owing to an increase in H. pylori infection. Irrespective of any region, the peptic ulcer cases are quite common because of unhealthy diet habits by many people. As per a recent article of 2019, published in Medscape, peptic ulcer disease affects approximately 4.6 million people annually in the United States with an estimated 10% of the US population having evidence of a duodenal ulcer at some time. Other conditions also include esophageal varices, gastritis, and cancer of the esophagus or stomach. In addition, the growing geriatric population and rise in applications of endoscopic hemostasis also contribute to the growth of the demand for treatments related to upper gastrointestinal bleedings.
Browse the Full report description and TOC at:
The key insights of the Gastrointestinal Bleeding Treatment Market report:
The report provides key statistics on the market status of the Gastrointestinal Bleeding Treatment market manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.
The report provides a basic overview of the industry including its definition, applications and manufacturing technology.
The Gastrointestinal Bleeding Treatment market report presents the company profile, product specifications, capacity, production value, and 2015-2020 market shares for key vendors.